Eri Watanabe

Evaluation of a routine second curettage for hydatidiform mole: a cohort study

F. Kikkawa, E. Yamamoto, K. Ino, 2020, International Journal of Clinical Oncology.

Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma

H. Kajiyama, E. Yamamoto, K. Niimi, 2022, Cancer medicine.

Cell surface membrane lysosome-associated membrane glycoprotein 2 promotes cell adhesion via abundant N-glycans in choriocarcinoma.

H. Kajiyama, E. Yamamoto, K. Niimi, 2021, Placenta.

Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma.

H. Kajiyama, Kae Nakamura, Tomoyasu Kato, 2023, Pharmacological research.

Short tandem repeat analysis to identify the causative pregnancy of high-risk gestational trophoblastic neoplasia: Molar versus nonmolar pregnancy and its relation to the outcome.

H. Kajiyama, E. Yamamoto, K. Niimi, 2021, Placenta.

Real‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer

K. Niimi, S. Tamauchi, N. Yoshikawa, 2024, Cancer medicine.

Next-generation genome sequencing of a matched normal-tumor pair from a patient with intractable gestational choriocarcinoma: A case report

H. Kajiyama, F. Kikkawa, M. Hatakeyama, 2021, Molecular and clinical oncology.